1. Home
  2. VRAX vs SDST Comparison

VRAX vs SDST Comparison

Compare VRAX & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$1.24

Market Cap

1.5M

Sector

Health Care

ML Signal

HOLD

Logo Stardust Power Inc.

SDST

Stardust Power Inc.

HOLD

Current Price

$0.01

Market Cap

1.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAX
SDST
Founded
2013
2022
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
1.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
VRAX
SDST
Price
$1.24
$0.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
150.3K
★ 66.3M
Earning Date
11-20-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.02
52 Week High
$13.19
$5.22

Technical Indicators

Market Signals
Indicator
VRAX
SDST
Relative Strength Index (RSI) 21.48 21.28
Support Level $0.16 N/A
Resistance Level $3.01 $0.36
Average True Range (ATR) 0.29 0.01
MACD -0.05 0.01
Stochastic Oscillator 2.69 1.12

Price Performance

Historical Comparison
VRAX
SDST

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About SDST Stardust Power Inc.

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

Share on Social Networks: